Comment: cost-effective pharmaceutical care for HIV disease.
Hoar
M E
ME
D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D015215:Zidovudine / Q000191:economics* / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D015215:Zidovudine